Enthera

Enthera Pharmaceuticals is a biotechnology company dedicated to building a first-class biologics pipeline for several underserved autoimmune diseases, with a focus on Type 1 Diabetes (T1D) and Inflammatory Bowel Disease (IBD). Their goal is to develop disease-modifying therapies by preserving and restoring cellular and organ function to improve outcomes in these conditions.